Your session will expire automatically in 0 seconds.
LEADER 00000cam 2200000 a 4500
001 ocn820450840
003 OCoLC
005 20130510024706.0
008 121128s2013 nyuaf b 001 0 eng
010 2012047686
016 7 101596695|2DNLM
019 808772057
020 9781615190676|qpaperback|c$25.95
020 1615190678|qpaperback
020 |z9781615191659 (ebk.)
020 |z1615191658 (ebk.)
035 (OCoLC)808772057
035 (OCoLC)820450840|z(OCoLC)808772057
035 (OCoLC)808772057
040 DNLM/DLC|beng|cDLC|dIG#|dNLM|dBDX|dYDXCP|dBTCTA|dKLP|dOCO
|dJAG|dOCLCO|dABG
049 CKEA
050 4 RC643|b.W36 2013
060 10 QZ 11 AA1
082 00 616.99/419042|223
100 1 Wapner, Jessica.
245 14 The Philadelphia chromosome :|ba mutant gene and the quest
to cure cancer at the genetic level /|cJessica Wapner ;
foreword by Robert A. Weinberg.
264 1 New York, NY :|bThe Experiment, LLC :|bDistributed by
Workman Pub. Co.,|c2013.
300 xiii, 303 pages, 8 unnumbered pages of plates :
|billustrations (some color) ;|c24 cm
336 text|btxt|2rdacontent
337 unmediated|bn|2rdamedia
338 volume|bnc|2rdacarrier
500 "This book draws extensively from interviews [the author]
conducted with those who lived this story. Chronic myeloid
leukemia (CML), the blood cancer that is this book's focus,
is alternately referred to as chronic myelogenous
leukemia."--Author's note.
504 Includes bibliographical references (pages 283-290) and
index.
505 0 Down to the bone : February 2012 -- The chromosome and the
disease : 1959-1990. The first clue ; Three hundred words
; Investigating a chicken virus ; Right number, wrong
place ; The surprising source of the chicken cancer gene ;
Consummate instigators ; Where the kinase hangs the keys ;
A chemical amputation ; Stripping away the fur and the fat
; A funny new protein ; The first sign of a human cancer
gene ; Spelling out the translocation ; "That word is
oncogenes" -- Rational design : 1983-1998. Becoming a
doctor, and then a scientist ; Turning a protein into a
drug target ; A machine with a virus for a motor ;
Plucking the low-hanging fruit ; A drug in search of a
disease; Two endings ; Getting out of Boston ; Killing
cells ; Gain and loss ; "Not over my dead body will this
compound go into man" -- Human trials : 1998-2001. The
quickest answer ; Getting to 200 milligrams ; The one
thing they didn't have ; Buzz in the chat rooms ; Saving
their own lives ; A response rate of one hundred percent ;
Good stressful ; Putting it in writing ; A truckload of
data ; The fathers of victory -- Aftermath. A price to pay
; Showing a weakness ; The first five years ; The second
generation ; A Gleevec for every cancer -- Survival time.
520 This work focuses on what is widely viewed as the 'poster
child' of rational drug development in the cancer research
world. The history of the founding of a genetic mutant
chromosome in the indication of Chronic myeloid leukemia
disease, and the subsequent development of "Gleevec," is
the keynote of this astounding publication.
600 10 Hungerford, David S.,|d1938-
650 0 Chronic myeloid leukemia|xHistory.
650 0 Chronic myeloid leukemia|xGenetic aspects.
650 0 Cancer|xGenetic aspects.
650 0 Cancer|xResearch.
650 0 Mutation (Biology)
650 0 Imatinib.
650 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive|xhistory
|zUnited States.
650 12 Philadelphia Chromosome|zUnited States.
650 22 Fusion Proteins, bcr-abl|xhistory|zUnited States.
650 22 Genetic Therapy|xhistory|zUnited States.
700 1 Weinberg, Robert A.|q(Robert Allan),|d1942-
938 Ingram|bINGR|n9781615190676
938 Brodart|bBROD|n103868143
938 YBP Library Services|bYANK|n9618972
938 Baker and Taylor|bBTCP|nBK0012006701
994 92|bCKE